16th Mar 2015 7:00 am |
RNS |
BRILINTA PEGASUS-TIMI 54 STUDY |
10th Mar 2015 6:24 pm |
RNS |
Filing of Form 20-F with SEC |
10th Mar 2015 11:00 am |
RNS |
Annual Financial Report |
6th Mar 2015 7:00 am |
RNS |
ASTRAZENECA REFINES ITS FINANCIAL REPORTING |
4th Mar 2015 11:54 am |
RNS |
AZ TO PARTICIPATE IN US FDA EMDAC |
3rd Mar 2015 7:05 am |
RNS |
Acquisition of Rights to Actavis' Portfolio |
2nd Mar 2015 3:00 pm |
RNS |
Total Voting Rights |
17th Feb 2015 7:00 am |
RNS |
Directorate Change |
16th Feb 2015 7:00 am |
RNS |
PULMICORT RESPULES® US PATENT LITIGATION DECISION |
5th Feb 2015 7:02 am |
RNS |
AZ to acquire Actavis' US respiratory portfolio |
5th Feb 2015 7:00 am |
RNS |
Final Results |
4th Feb 2015 9:00 am |
RNS |
Notice of Results |
2nd Feb 2015 2:00 pm |
RNS |
Total Voting Rights |
22nd Jan 2015 7:00 am |
RNS |
MAA FOR GOUT TREATMENT LESINURAD ACCEPTED BY EMA |
14th Jan 2015 7:43 am |
RNS |
BRILINTA PEGASUS STUDY MEETS PRIMARY ENDPOINT |
2nd Jan 2015 2:00 pm |
RNS |
Total Voting Rights |
19th Dec 2014 5:40 pm |
RNS |
LYNPARZA APPROVED BY THE US FDA |
18th Dec 2014 7:00 am |
RNS |
LYNPARZAT APPROVED IN THE EUROPEAN UNION |
9th Dec 2014 7:00 am |
RNS |
MOVENTIG approved in the EU for OIC |
5th Dec 2014 5:03 pm |
RNS |
Jury verdict favours AZ in Nexium litigation |
2nd Dec 2014 7:00 am |
RNS |
New Drug Application for IRESSA accepted by US FDA |
1st Dec 2014 2:00 pm |
RNS |
Blocklisting Interim Review |
1st Dec 2014 2:00 pm |
RNS |
Total Voting Rights |
26th Nov 2014 7:00 am |
RNS |
POSITIVE RESULTS FROM BRODALUMAB PHASE III STUDY |
24th Nov 2014 4:00 pm |
RNS |
Publication of Final Terms |
24th Nov 2014 7:00 am |
RNS |
DUAKLIR GENUAIR APPROVED IN THE EU FOR COPD |
19th Nov 2014 5:00 pm |
RNS |
Launch and Pricing of a ?750m Bond |
19th Nov 2014 9:41 am |
RNS |
Stabilisation Notice |
18th Nov 2014 7:00 am |
RNS |
AZ strategy on track to deliver growth and value |
17th Nov 2014 4:00 pm |
RNS |
Publication of Supplementary Prospectus |
12th Nov 2014 7:00 am |
RNS |
AMGEN & AZ POSITIVE PHASE III BRODALUMAB RESULTS |
10th Nov 2014 2:27 pm |
RNS |
Director/PDMR Shareholding |
6th Nov 2014 7:04 am |
RNS |
ASTRAZENECA TO DIVEST MYALEPT TO AEGERION |
6th Nov 2014 7:00 am |
RNS |
3rd Quarter Results |
6th Nov 2014 7:00 am |
RNS |
3rd Quarter Results |
5th Nov 2014 7:00 am |
RNS |
Notice of Results |
4th Nov 2014 7:00 am |
RNS |
MEDIMMUNE ACQUIRES DEFINIENS |
3rd Nov 2014 3:00 pm |
RNS |
Total Voting Rights |
3rd Nov 2014 7:00 am |
RNS |
AZ COMPLETES STRATEGIC TRANSACTION WITH ALMIRALL |
30th Oct 2014 7:00 am |
RNS |
US FDA APPROVES ONCE-DAILY XIGDUOT XR TABLETS |